Pharmaceuticals: Major

Ratio between share price and earnings per share. A low ratio could indicate undervaluation.

Ratio of dividends in the last 12 months to current share price.

Revenue increase compared to the same quarter one year ago.

Net income increase compared to the same quarter one year ago.

Profitability of the last quarter.

A higher ratio indicates a higher risk. The ratio is difficult to compare between industries.

Discounted cash flow valuation vs. current price. Positive = undervalued, negative = overvalued.